Zobrazeno 1 - 10
of 18
pro vyhledávání: '"W O, Wilkison"'
Autor:
L. Kler, D. J. Dorey, W. O. Wilkison, S. Walker, Robert L. Dobbins, Robin L. O'Connor-Semmes, A. P. Sykes, J. D. Lorimer
Publikováno v:
Diabetes, Obesity and Metabolism. 17:94-97
We compared the efficacy of twice-daily doses of remogliflozin etabonate (RE) and once-daily pioglitazone with placebo for reduction in glycated haemoglobin (HbA1c) concentration. In this 12-week, double-blind, randomized, active- and placebo-control
Autor:
Robin L. O'Connor-Semmes, S. Walker, S. R. Almond, A. P. Sykes, Robert L. Dobbins, G. L. Kemp, L. Kler, W. O. Wilkison
Publikováno v:
Diabetes, obesitymetabolism. 17(1)
The sodium-dependent glucose transporter 2 (SGLT2) inhibitor remogliflozin etabonate (RE) was evaluated in a 12-week, double-blind, randomized, placebo- and active-controlled, parallel-group study. A total of 252 newly diagnosed and drug-naive people
Autor:
Y.-D. C. Halvorsen, W. O. Wilkison, Allen C. Clermont, Bruce M. Spiegelman, M Brittis, T. J. Mcgovern, S E Bursell
Publikováno v:
Journal of Clinical Investigation. 92:2872-2876
1-Butyryl-glycerol (monobutyrin) is a simple lipid product of adipocytes with angiogenic activity. Recent studies have shown that the biosynthesis of this compound is tightly linked to lipolysis, a process associated with changes in blood flow. We no
Publikováno v:
Journal of Biological Chemistry. 266:16886-16891
1-Butyrylglycerol (monobutyrin) is a novel angiogenic compound that is synthesized and secreted during the differentiation of 3T3-F442A preadipocytes into adipocytes. To study the regulation of monobutyrin biosynthesis we have developed an assay util
Publikováno v:
Journal of Biological Chemistry. 265:477-482
The mouse adipsin gene encodes a serine protease with complement factor D activity that is expressed during adipocyte differentiation and is deficient in several animal models of obesity. We have investigated the regulation of adipsin expression by t
Autor:
W O, Wilkison
Publikováno v:
IDrugs : the investigational drugs journal. 2(8)
HP-228 is a cytokine regulating agent from Trega Biosciences (formerly Houghten Pharmaceuticals). It is in phase II trials for the management of post-surgical pain and inflammation [195065]. The drug was indicated for the treatment of diabetes, obesi
Autor:
D A, Winegar, P J, Brown, W O, Wilkison, M C, Lewis, R J, Ott, W Q, Tong, H R, Brown, J M, Lehmann, S A, Kliewer, K D, Plunket, J M, Way, N L, Bodkin, B C, Hansen
Publikováno v:
Journal of lipid research. 42(10)
Fenofibrate is a member of the fibrate class of hypolipidemic agents used clinically to treat hypertriglyceridemia and mixed hyperlipidemia. The fibrates were developed primarily on the basis of their cholesterol and triglyceride lowering in rodents.
Autor:
A, Sen, Y R, Lea-Currie, D, Sujkowska, D M, Franklin, W O, Wilkison, Y D, Halvorsen, J M, Gimble
Publikováno v:
Journal of cellular biochemistry. 81(2)
The current study was done to assess if heterogeneity existed in the degree of adipogenesis in stromal cells (preadipocytes) from multiple donors. In addition to conventional lipid-based methods, we have employed a novel signal amplification technolo
Publikováno v:
The Journal of biological chemistry. 269(46)
Transcription of the adipocyte-specific adipsin gene is dramatically reduced in the adipose tissue of a number of genetically and chemically-induced obese rodents. To map the region of the adipsin gene that confers this response to obesity, transgeni
Autor:
W O, Wilkison, B M, Spiegelman
Publikováno v:
The Journal of biological chemistry. 268(4)
Monobutyrin (1-butyrylglycerol) is a simple lipid secreted by adipocytes that stimulates both angiogenesis and vasodilation of microvascular beds. While monobutyrin production is increased during lipolysis, little is known about the biosynthetic path